Upload Avatar (500 x 500)
Lin Huiping
Basic Medical Sciences
Guangzhou Medical University
Guangdong
Language: English, Chinese
Contact
Atherosclerosis Macrophages Macropinocytosis Lymphangiogenesis Estrogen Immunology Clinical Drugs Research Mechanism Translational Medicine
Areas of Focus
  • Atherosclerosis
  • Macrophages
  • Macropinocytosis
  • Lymphangiogenesis
  • Estrogen
Work Experience
  • Current - Guangzhou Medical University - Distinguished Professor
Academic Background & Achievements
  • PhD: Studied in the USA
  • Achievement: Awarded 'Outstanding PhD Graduate' in the USA
Publications
  • Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis., Lin HP, Singla B, Ahn W, Ghoshal P, Blahove M, Cherian-Shaw M, Chen A, Haller A, Hui DY, Dong K, Zhou J, White J, Stranahan AM, Jasztal A, Lucas R, Stansfield BK, Fulton D, Chlopicki S, Csányi G., 2022
  • Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs., Lin HP, Singla B, Ghoshal P, Faulkner JL, Cherian-Shaw M, O'Connor PM, She JX, Belin de Chantemele EJ, Csányi G., 2018
  • Identification of key genes in the pathogenesis of preeclampsia via bioinformatic analysis and experimental verification., Gao Y, Wu Z, Liu SM, Chen Y, Zhao G and Lin HP., 2023
  • Mutation of aspartic acid 262 on estrogen receptor abrogates estradiol signaling pathway., Xu X, Yu H, Zhu S, Li P, Li X, Gao Y, Xiang Y, Zhao G, Simoncini T & Lin HP., 2023
  • Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling., Singla B*, Lin HP*(co-first author), Ahn W, White J, Csányi G., 2021
Awards
  • 2019: ATVB Scientific Sessions Travel Grants for Early Career Investigators
  • 2019: Junior Investigator Award for Women
  • 2018: ATVB Young Investigators Travel Award
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.